Medifast (MED) Enterprise Value (2010 - 2026)

Medifast's Enterprise Value history runs 17 years deep, the most recent figure standing at -$168.9 million for Q1 2026.

• Quarterly Enterprise Value fell 2.64% year-over-year to -$168.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$168.9 million (down 2.64% YoY) and the FY2025 annual result came in at -$167.3 million, down 3.04% from the prior year.
• Enterprise Value was -$168.9 million for Q1 2026 at Medifast, down from -$167.3 million in the prior quarter.
• Across five years, Enterprise Value topped out at -$61.1 million in Q2 2022 and bottomed at -$173.5 million in Q3 2025.
• A 5-year average of -$141.7 million and a median of -$157.8 million in 2023 frame the typical range for Enterprise Value.
• Annual changes were most pronounced in 2022 — Enterprise Value soared 69.07% — and 2023, when it plunged 141.37%.
• Medifast's Enterprise Value stood at -$87.7 million in 2022, then tumbled by 71.1% to -$150.0 million in 2023, then slipped by 8.2% to -$162.3 million in 2024, then slipped by 3.04% to -$167.3 million in 2025, then retreated by 1.0% to -$168.9 million in 2026.
• Business Quant data shows MED's Enterprise Value at -$168.9 million in Q1 2026, -$167.3 million in Q4 2025, and -$173.5 million in Q3 2025.